Mersana Therapeutics Inc (MRSN)
Mersana Therapeutics Inc
(MRSN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 122,825 | 128,885 | 184,082 | 135,338 | 230,057 |
| Marketable Securities | 151,094 | 151,827 | 106,044 | 89,790 | N/A |
| Receivables | N/A | 30,000 | N/A | N/A | N/A |
| TOTAL | $281,807 | $319,219 | $300,037 | $237,079 | $241,470 |
| Non-Current Assets | |||||
| PPE Net | 3,994 | 3,985 | 3,136 | 2,854 | 2,549 |
| Other Non-Current Assets | 10,394 | 11,136 | 11,677 | 12,418 | 14,248 |
| TOTAL | $14,388 | $15,121 | $14,813 | $15,272 | $16,797 |
| Total Assets | $296,195 | $334,340 | $314,850 | $252,351 | $258,267 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 18,156 | 13,951 | 13,732 | 8,158 | 9,775 |
| Accrued Expenses | 32,588 | 43,184 | 41,204 | 34,256 | 27,475 |
| Other current liabilities | 985 | 990 | 237 | 234 | 231 |
| TOTAL | $83,402 | $91,533 | $88,794 | $71,470 | $56,463 |
| Non-Current Liabilities | |||||
| Long Term Debt | 25,004 | 24,929 | 24,853 | 24,777 | 24,702 |
| Deferred Revenues | 28,769 | 30,610 | 30,924 | 26,230 | 16,578 |
| Other Non-Current Liabilities | 7,913 | 8,778 | 9,557 | 10,386 | 10,956 |
| TOTAL | $148,499 | $150,750 | $135,827 | $46,847 | $61,278 |
| Total Liabilities | $231,901 | $242,283 | $224,621 | $118,317 | $117,741 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 4,575 | 4,321 | 3,991 | 3,887 | 3,880 |
| Common Shares | 11 | 11 | 10 | 10 | 9 |
| Retained earnings | -710,854 | -654,691 | -609,767 | -549,956 | -497,737 |
| Other shareholders' equity | 12 | -152 | -231 | -126 | 0 |
| TOTAL | $64,294 | $92,057 | $90,229 | $134,034 | $140,526 |
| Total Liabilities And Equity | $296,195 | $334,340 | $314,850 | $252,351 | $258,267 |